* Personalis Inc PSNL.OQ reported a quarterly adjusted
loss
of 24 cents per share for the quarter ended in January, higher
than the same quarter last year, when the company reported EPS
of -50 cents. The mean expectation of six analysts for the
quarter was for a loss of 37 cents per share. Wall Street
expected results to range from -41 cents to -32 cents per share.
* Revenue rose 35.2% to $22.58 million from a year ago;
analysts
expected $19.26 million.
* Personalis Inc's reported EPS for the quarter was a loss
of 24
cents.
* The company reported a quarterly loss of $12.8 million.
* Personalis Inc shares had risen by 173.5% this quarter and
gained 52.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 3.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Personalis Inc is
$4.00
This summary was machine generated from LSEG data August 7 at
09:02 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.37 -0.24 Beat
Mar. 31 2024 -0.41 -0.26 Beat
Dec. 31 2023 -0.50 -0.54 Missed
Sep. 30 2023 -0.53 -0.48 Beat